Scilex Holding Company — Form 8-K Summary
Reporting date: February 8, 2023; filed February 9, 2023. The filing reports an amended and restated standby equity purchase agreement with YA II PN, LTD. (“Yorkville”).
Business Context and Reporting Period
Scilex Holding Company is a Delaware corporation whose common stock and warrants trade on Nasdaq under the symbols SCLX and SCLXW. This Form 8-K is a transaction report and does not provide quarterly or annual operating results.
Material Financing Terms
- Scilex may, but is not obligated to, sell Yorkville up to $500 million of common stock from time to time at Scilex’s discretion.
- The arrangement remains available until the first day of the month following the 36-month anniversary of the date the initial registration statement became effective.
- Shares sold in an advance will generally be priced at 98% of the volume-weighted average price during the applicable one-day pricing period.
- Each advance is limited to no more than 200% of the average daily trading volume during the five trading days preceding the advance notice.
- Yorkville generally may not acquire shares that would cause it and its affiliates to exceed 4.99% of the company’s voting power or common stock, or exceed the stated 19.9% exchange cap based on shares outstanding as of November 17, 2022. The exchange cap may not apply under specified minimum-price conditions.
Material Changes and Unusual Items
- The amended and restated agreement dated February 8, 2023 supersedes the original agreement dated November 17, 2022.
- Scilex previously paid Yorkville a $10,000 structuring fee and issued 250,000 commitment shares under the original agreement.
- The registration statement covering the commitment shares and potential advance shares was filed November 30, 2022 and declared effective by the SEC on December 9, 2022.
- As of the filing date, no advances had been requested or completed under the original agreement.
- Future sales could result in dilution to existing stockholders and would be made at a discount to the applicable VWAP.
Financial Metrics, Liquidity, Guidance and Risks
The filing does not provide revenue, profit, cash flow, margins, debt, cash balances, liquidity ratios, or operating guidance. It also does not quantify the number of shares that could be issued under the facility. Yorkville’s purchase obligations are subject to conditions, including an effective registration statement and other agreement requirements.
The securities are offered and sold in reliance on the Securities Act Section 4(a)(2) exemption, with Yorkville representing that it is an accredited investor. The agreement’s representations, warranties, and covenants should be read together with Scilex’s other SEC filings.
Investor Verification Checklist
- Verify whether Scilex has subsequently requested or completed any advances and the number and price of shares issued.
- Review the full amended and restated purchase agreement, including omitted exhibits and schedules upon request.
- Assess potential dilution from the $500 million facility, the 250,000 commitment shares, and any related resale activity.
- Confirm the applicable share-ownership limitations, exchange-cap exceptions, and minimum-price provisions.
- Review subsequent periodic reports for the company’s cash needs, liquidity, operating results, and use of proceeds.